Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

Case study: See Below

Case study: See Below Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme

Lilly expands dermatology portfolio with $1.1bn Dermira deal

Lilly expands dermatology portfolio with $1.1bn Dermira deal If approved, Lilly’s newly acquired drug will closely compete with Sanofi/Regenerons’s Dupixent (dupilumab) which grew 142% in the  last quarter to $637m.

Almirall eyes $62m takeover of multicytokine specialist Bioniz

Almirall eyes $62m takeover of multicytokine specialist Bioniz If approved, that would be a rival to Sanofi and Regeneron’s fast-growing atopic dermatitis therapy Dupixent (dupilumab).

Novartis picks up inclisiran after completion of MedCo acquisition

Novartis picks up inclisiran after completion of MedCo acquisition This dosing schedule means that MedCo’s drug could pose a major challenge to established drugs in the class, including Amgen’s Repatha (evolocumab) and Sanofi/Regeneron’s Praluent (alirocumab).

GSK files anti-BCMA drug for myeloma after second trial win

GSK files anti-BCMA drug for myeloma after second trial win Other drugs making their way through development include bispecific antibodies from Amgen ( AMG 420), Regeneron (REGN5458) and Bluebird Bio/Bristol-Myers Squibb (CC-92369), as well as ADCs from AstraZeneca (MEDI2228)

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics